首页 > 市场调查报告书 > 医疗设备

体外诊断生技设备

市场调查报告书

商品编码

1561065

免疫组织化学市场规模、份额、成长分析、按应用、按最终用户、按地区 - 行业预测，2024-2031

Immunohistochemistry Market Size, Share, Growth Analysis, By Application (Application Diagnostic applications, Research applications), By End User (Hospitals & Diagnostic Laboratories), By Region - Industry Forecast 2024-2031

出版日期: 2024年09月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球免疫组化市场规模约29亿美元，预测期间（2024-2031年）复合年增长率为7.4%，从2023年的31亿美元上升，到2031年预计将达55亿美元。

全球免疫组织化学 (IHC) 市场是更广泛的生命科学和诊断市场中成长最快的部分，这主要是由癌症和其他慢性疾病的盛行率不断上升所推动的。 IHC是识别组织抗原和生物标记的重要技术，广泛应用于癌症诊断和监测、实现标靶治疗、阐明疾病途径。随着个人化医疗的进步和疾病的早期检测变得更加重要，对 IHC 技术的需求预计将迅速增加。该市场受益于领先公司持续的研发投资、新型生物标记的采用以及提高诊断准确性和效率的自动化 IHC 设备。市场按产品类型（抗体、试剂、仪器、套件）、应用（诊断、药物测试、研究）和最终用户（医院、诊断实验室、研究机构）进行细分。北美以强大的医疗基础设施、高癌症发病率以及广泛的研发活动而领先。紧随其后的是欧洲和亚太地区，由于医疗保健成本上升、患者人数不断增加以及对先进诊断技术的认识不断增强，预计后者将快速增长。全球 IHC 市场竞争激烈，F. Hoffmann-La Roche AG、Danaher Corporation、Agilent Technologies 和 Thermo Fisher Scientific 等主要企业推动创新和市场扩张。

市场概况
抗体
- 类型
- 一抗
- 二抗
- 克隆性质
- 单株抗体
- 多株抗体
- 试剂
- 组织学染色
- 封闭血清/试剂
- 呈色受质
- 固定试剂
- 有机溶剂
- 蛋白水解酶
- 冲淡
- 其他试剂（抗原活化液、稳定剂、品管、封固液）
- 装置
- 玻片染色系统
- 组织处理系统
- 幻灯片扫描仪
- 其他设备（数位病理学系统、组织学设备，例如自动盖片机、视觉化设备（明视野、萤光显微镜）、切片机、石蜡分配器、玻片贴标机、组织微阵列）
- 套件
- 人类免疫组化试剂套件
- 动物免疫组化试剂套件

免疫组织化学市场：依应用分类

市场概况
诊断用途
- 癌症
- 感染疾病
- 自体免疫疾病
- 肾臟疾病
- 神经系统疾病
- 其他疾病（眼科、心血管、皮肤科、牙科疾病）
研究用途
- 药物开发和测试
- 其他研究用途（干细胞研究/发育生物学）
- 法医学应用

免疫组织化学市场：依最终用户分类

市场概况
医院/诊断实验室
学术机构/委外研发机构（CRO）
其他最终用户（製药公司、生物製药公司、法医学实验室）

按地区分類的免疫组织化学市场规模

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

F. Hoffmann-La Roche Ltd.
Danaher Corporation
Agilent Technologies, Inc.
PHC Holdings Corporation
Thermo Fisher Scientific Inc.
Merck KGaA
Bio-Rad Laboratories, Inc.
Bio-Techne
Becton, Dickinson and Company
Takara Bio Inc.
Enzo Biochem Inc.
Sino Biological, Inc.
Sakura Finetek Japan Co., Ltd.
Cell Signaling Technology, Inc.
BIO SB
Miltenyi Biotec
OriGene Technologies, Inc.
EagleBio
Biocare Medical, LLC
Elabscience Bionovation Inc.
BioGenex
Diagnostic BioSystems Inc.
Histo-Line Laboratories
Rockland Immunochemicals, Inc.
Candor Bioscience GmbH
Genemed Biotechnologies, Inc.

简介目录

Product Code: SQMIG35H2224

Global Immunohistochemistry Market size was valued at around 2.9 billion in 2022 and is expected to rise from USD 3.1 billion in 2023 to reach a value of USD 5.5 billion by 2031, at a CAGR of 7.4% over the forecast period (2024-2031).

The Global Immunohistochemistry (IHC) Market is a rapidly growing sector within the broader life sciences and diagnostics markets, primarily driven by the increasing prevalence of cancer and other chronic diseases. IHC, a key technique for identifying tissue antigens and biomarkers, is widely used for diagnosing and monitoring cancer, enabling targeted therapy, and understanding disease pathways. With advancements in personalized medicine and a rising emphasis on early disease detection, the demand for IHC techniques is expected to surge. The market benefits from continuous R&D investments by major players, the introduction of novel biomarkers, and automated IHC instruments, which enhance diagnostic accuracy and efficiency. The market is segmented by product type (antibodies, reagents, equipment, kits), application (diagnostics, drug testing, research), and end-users (hospitals, diagnostic labs, research institutions). North America leads due to robust healthcare infrastructure, high cancer prevalence, and extensive R&D activities. Europe and Asia-Pacific follow, with the latter projected to witness the fastest growth due to rising healthcare expenditure, expanding patient pool, and increasing awareness of advanced diagnostic techniques. The global IHC market is highly competitive, with key players like F. Hoffmann-La Roche AG, Danaher Corporation, Agilent Technologies, and Thermo Fisher Scientific driving innovation and market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Immunohistochemistry Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Immunohistochemistry Market Segmental Analysis

Global Immunohistochemistry Market is segmented by Product, Application, and region. Based on Product, the market is segmented into Antibodies (Primary antibodies, Secondary antibodies) clonality (Monoclonal antibodies, Polyclonal antibodies), Reagents (Histological Stains, Blocking Sera and Reagents, Chromogenic Substrates, Fixation Reagents, Organic Solvents, Proteolytic Enzymes, Diluents, Other Reagents (Antigen Retrieval Solutions, Stabilizers, Controls, And Mounting Solutions)), Equipment (Slide-staining Systems, Tissue Processing Systems, Slide Scanners, Other Equipment (Digital Pathology Systems And Histology Equipment, Such As Automated Cover Slippers, Visualization Equipment (Bright-Field, Fluorescence Microscopes), Microtomes, Paraffin Dispensers, Slide Labelers, And Tissue Microarrays)), Kits (Human Immunohistochemistry Kits, Animal Immunohistochemistry Kits). Based on Application, the market is segmented into Application Diagnostic applications (Cancer, Infectious diseases, Autoimmune diseases, Nephrological diseases, Neurological diseases, Other diseases (Ophthalmic, Cardiovascular, Dermatological, And Dental Diseases), Research applications (Drug Development and Testing, Other research applications (Stem Cell Research and Developmental Biology), and Forensic applications. Based on End User, the market is segmented into Hospitals & Diagnostic Laboratories, Academic Institutions & Contract Research Organizations (CROs), Other end users (Pharmaceutical & Biopharma Companies, and Forensic Laboratories). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Immunohistochemistry Market

One of the major drivers of the Global Immunohistochemistry Market is the rising incidence of cancer worldwide. According to the World Health Organization (WHO), cancer is one of the leading causes of death globally, with millions of new cases diagnosed annually. Immunohistochemistry is a vital tool in oncology, providing crucial information for the diagnosis, prognosis, and selection of targeted therapies. With the increasing number of cancer cases, the demand for accurate and reliable diagnostic methods has surged, pushing the adoption of IHC techniques in clinical settings. Moreover, advancements in IHC, such as the development of new antibodies and detection systems, enhance the precision of cancer diagnostics, leading to better patient management and outcomes. As personalized medicine continues to gain traction, the role of IHC in selecting appropriate therapeutic strategies further reinforces its market growth.

Restraints in the Global Immunohistochemistry Market

The high cost of immunohistochemistry instruments and reagents is a significant restraint to the market's growth. IHC requires sophisticated equipment, including automated staining systems and advanced microscopes, which involve substantial capital investment. Additionally, the cost of reagents, such as antibodies and detection kits, can be high, especially when multiple tests are needed for comprehensive diagnosis. This makes IHC relatively expensive compared to other diagnostic techniques, limiting its adoption in regions with limited healthcare budgets or underdeveloped healthcare infrastructure. In emerging economies, the cost burden can be a significant barrier for smaller hospitals, clinics, and diagnostic labs that lack the financial resources to invest in advanced diagnostic technologies. Furthermore, the ongoing maintenance and operational costs associated with IHC instruments add to the overall expenses, creating a financial constraint for healthcare providers.

Market Trends of the Global Immunohistochemistry Market

The integration of automation and digital pathology in immunohistochemistry represents a significant trend shaping the market. Automated IHC instruments offer several advantages, such as reduced manual errors, enhanced reproducibility, and faster turnaround times, which are crucial for accurate and timely diagnosis. This trend is particularly important in high-throughput settings like hospitals and diagnostic laboratories. Furthermore, the integration of digital pathology with IHC allows for the digitization of slides, enabling remote analysis, collaboration, and AI-based image analysis. This advancement not only enhances diagnostic accuracy but also facilitates the efficient storage and retrieval of histopathological data, improving overall workflow efficiency. Leading market players are increasingly investing in developing automated IHC platforms integrated with digital pathology solutions, anticipating a robust adoption rate in the coming years due to their potential to transform pathology practices globally.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Ecosystem of the Market
Value Chain Analysis
Pricing Analysis
Patent Analysis
Case Study Analysis
Technology Analysis
Regulatory Analysis
Supply Chain Analysis
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Immunohistochemistry Market by Product

Market Overview
Antibodies
- Type
- Primary antibodies
- Secondary antibodies
- clonality
- Monoclonal antibodies
- Polyclonal antibodies
- Reagents
- Histological Stains
- Blocking Sera and Reagents
- Chromogenic Substrates
- Fixation Reagents
- Organic Solvents
- Proteolytic Enzymes
- Diluents
- Other Reagents (Antigen Retrieval Solutions, Stabilizers, Controls, And Mounting Solutions)
- Equipment
- Slide-staining Systems
- Tissue Processing Systems
- Slide Scanners
- Other Equipment (Digital Pathology Systems And Histology Equipment, Such As Automated Cover Slippers, Visualization Equipment (Bright-Field, Fluorescence Microscopes), Microtomes, Paraffin Dispensers, Slide Labelers, And Tissue Microarrays)
- Kits
- Human Immunohistochemistry Kits
- Animal Immunohistochemistry Kits

Immunohistochemistry Market by Application

Market Overview
Diagnostic applications
- Cancer
- Infectious diseases
- Autoimmune diseases
- Nephrological diseases
- Neurological diseases
- Other diseases (Ophthalmic, Cardiovascular, Dermatological, And Dental Diseases)
Research applications
- Drug Development and Testing
- Other research applications (Stem Cell Research And Developmental Biology)
- Forensic applications

Immunohistochemistry Market by End User

Market Overview
Hospitals & Diagnostic Laboratories
Academic Institutions & Contract Research Organizations (CROs)
Other end users (Pharmaceutical & Biopharma Companies, and Forensic Laboratories)

Immunohistochemistry Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

F. Hoffmann-La Roche Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PHC Holdings Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enzo Biochem Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sino Biological, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sakura Finetek Japan Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cell Signaling Technology, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIO SB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OriGene Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EagleBio
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocare Medical, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elabscience Bionovation Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioGenex
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Diagnostic BioSystems Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Histo-Line Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rockland Immunochemicals, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Candor Bioscience GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genemed Biotechnologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments